← Mechanisms of action
Lyssavirus rabies
ORGANISMLyssavirus rabies
Drugs acting on this target (31)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| abhayrab rabies vaccine | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| attenuated rabies vaccine (Pasteur) | Immunity, active | marketed | Vaccine | Lyssavirus rabies immunity, active |
| chad155-rg | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| chadox2 rabg | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| cv7201 mrna | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| cv7202 | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| cv8102 | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| gsk3903133a | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| hdcrv | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| inactivated rabies vaccine (Imovax) | Immunity, active | approved | Vaccine | Lyssavirus rabies immunity, active |
| pika rabies vaccine | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| PvRII (Verorab) | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| rabies vaccine | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| rabies vaccine (purified chick embryo cell vaccine) (RabAvert) | Immunity, active | approved | Vaccine | Lyssavirus rabies immunity, active |
| rabies vaccine adsorbed (BioRab) | Immunity, active | approved | Vaccine | Lyssavirus rabies immunity, active |
| rabies vaccine, human isolate | Immunity, active | approved | Vaccine | Lyssavirus rabies immunity, active |
| rabies vaccine, rabbit isolate | Immunity, active | approved | Vaccine | Lyssavirus rabies immunity, active |
| rabix-vc | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| rbi-4000 | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| recombinant human adenovirus type 5 | Immunity, active | experimental | Biological | Lyssavirus rabies immunity, active |
| vcp65 | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| vrvg-2 | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| wistar rabies virus strain pm-1503-3m vaccine | Immunity, active | experimental | Vaccine | Lyssavirus rabies immunity, active |
| antirabies serum (equine) | Immunity, passive | experimental | Animal product | Lyssavirus rabies immunity, passive |
| foravirumab | Immunity, passive | experimental | mAb | Lyssavirus rabies immunity, passive |
| mix of cr-57 and cr-4098 | Immunity, passive | experimental | mAb | Lyssavirus rabies immunity, passive |
| rabies immune globulin (human) (HyperRAB) | Immunity, passive | approved | Biological | Lyssavirus rabies immunity, passive |
| rafivirumab | Immunity, passive | experimental | mAb | Lyssavirus rabies immunity, passive |
| syn023 | Immunity, passive | experimental | mAb | Lyssavirus rabies immunity, passive |
| cbb 1 | Inhibitor | experimental | mAb | Lyssavirus rabies inhibitor |
| gr1801 | Inhibitor | experimental | mAb | Lyssavirus rabies inhibitor |